Allison Keshishian

2.0k total citations
82 papers, 1.4k citations indexed

About

Allison Keshishian is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Allison Keshishian has authored 82 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Cardiology and Cardiovascular Medicine, 35 papers in Internal Medicine and 15 papers in Economics and Econometrics. Recurrent topics in Allison Keshishian's work include Atrial Fibrillation Management and Outcomes (63 papers), Venous Thromboembolism Diagnosis and Management (35 papers) and Cardiac Arrhythmias and Treatments (24 papers). Allison Keshishian is often cited by papers focused on Atrial Fibrillation Management and Outcomes (63 papers), Venous Thromboembolism Diagnosis and Management (35 papers) and Cardiac Arrhythmias and Treatments (24 papers). Allison Keshishian collaborates with scholars based in United States, United Kingdom and Denmark. Allison Keshishian's co-authors include Jack Mardekian, Gregory Y.H. Lip, Xianying Pan, Xuemei Luo, Anagha Nadkarni, Ruslan Horblyuk, Hüseyin Yüce, Lisa Rosenblatt, Kiran Gupta and Steven Deitelzweig and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Allison Keshishian

78 papers receiving 1.4k citations

Peers

Countries citing papers authored by Allison Keshishian

Since Specialization

Citations

This map shows the geographic impact of Allison Keshishian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Keshishian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Keshishian more than expected).

Fields of papers citing papers by Allison Keshishian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Keshishian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Keshishian. The network helps show where Allison Keshishian may publish in the future.

Co-authorship network of co-authors of Allison Keshishian

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Keshishian. A scholar is included among the top collaborators of Allison Keshishian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Keshishian. Allison Keshishian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Predicting individual treatment response in alcohol use disorders: a reverse translational proof-of-concept study	Translational Psychiatry	Allison Keshishian, Min Li et al.	1
2	Treatment patterns, healthcare resource utilization, and costs in Medicare patients with diffuse large B-cell lymphoma: a retrospective claims analysis (2015–2020)	Journal of Medical Economics	Anindit Chhibber, Allison Keshishian et al.	0
3	Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation	Journal of Thrombosis and Thrombolysis	Brett D. Atwater, Manuela Di Fusco et al.	5
4	Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation	Journal of Thrombosis and Thrombolysis	Brett D. Atwater, Jennifer D. Guo et al.	2
5	Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States	Clinical Cardiology	Mintu P. Turakhia, Jennifer D. Guo et al.	19
6	Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database	PLoS ONE	Muhammad Bilal Munir, Patrick Hlavacek et al.	3
7	Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity	Advances in Therapy	Amol D. Dhamane, Mauricio Ferri et al.	7
8	CONTEMPORARY PREVALENCE ESTIMATES OF UNDIAGNOSED AND DIAGNOSED ATRIAL FIBRILLATION IN THE UNITED STATES	Journal of the American College of Cardiology	Mintu P. Turakhia, Jennifer D. Guo et al.	0
9	EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS	Journal of the American College of Cardiology	Steven Deitelzweig, Allison Keshishian et al.	1
10	Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure	PLoS ONE	Alpesh Amin, Alessandra Bassalobre García et al.	22
11	Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population	BMC Cardiovascular Disorders	Kiran Gupta, Jeffrey Trocio et al.	18
12	COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE	Journal of the American College of Cardiology	Steve Deitelzweig, Allison Keshishian et al.	3
13	Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients	Stroke	Gregory Y.H. Lip, Allison Keshishian et al.	225
14	Abstract 16462: Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases	Circulation	Steve Deitelzweig, Allison Keshishian et al.	1
15	Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice	Thrombosis and Haemostasis	Xiaoyan Li, Steve Deitelzweig et al.	122
16	Evaluating Asthma-Related Expenses And Health Care Resource Utilization Among Children In The United States Medicaid Population	Value in Health	Yunhe Zhao, Allison Keshishian et al.	2
17	Examination of the Economic Burden of Dyslipidemia in the Veterans Health Administration Population	Value in Health	Allison Keshishian, Liang Xie et al.	1
18	Demographic and Socioeconomic Characteristics that Impact Selection of Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients	Value in Health	Allison Keshishian, Lin Xie et al.	1
19	REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS	Journal of the American College of Cardiology	Gregory Y.H. Lip, Allison Keshishian et al.	7
20	Assessing the economic burden of u.s. Medicare patients diagnosed with non-hodgkin’s lymphoma	Value in Health	Lin Xie, Allison Keshishian et al.	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact